Marina Boni

2.0k total citations · 1 hit paper
50 papers, 1.3k citations indexed

About

Marina Boni is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Marina Boni has authored 50 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 17 papers in Molecular Biology and 9 papers in Genetics. Recurrent topics in Marina Boni's work include Acute Myeloid Leukemia Research (26 papers), Chronic Myeloid Leukemia Treatments (12 papers) and Acute Lymphoblastic Leukemia research (8 papers). Marina Boni is often cited by papers focused on Acute Myeloid Leukemia Research (26 papers), Chronic Myeloid Leukemia Treatments (12 papers) and Acute Lymphoblastic Leukemia research (8 papers). Marina Boni collaborates with scholars based in Italy, South Africa and United States. Marina Boni's co-authors include Paolo Bernasconi, Mario Lazzarino, Mario Cazzola, Francesco Passamonti, Cristiana Pascutto, Rosangela Invernizzi, Erica Travaglino, Luca Arcaini, Matteo Giovanni Della Porta and Margherita Maffioli and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of the New York Academy of Sciences.

In The Last Decade

Marina Boni

45 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic Factors and Life Expectancy in Myelodysplastic Syndromes Classified According to WHO Criteria: A Basis for Clinical Decision Making

2005 618 citations Luca Malcovati, Rosangela Invernizzi et al. profile →

Peers

Countries citing papers authored by Marina Boni

Since Specialization

Citations

This map shows the geographic impact of Marina Boni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Boni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Boni more than expected).

Fields of papers citing papers by Marina Boni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina Boni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Boni. The network helps show where Marina Boni may publish in the future.

Co-authorship network of co-authors of Marina Boni

This figure shows the co-authorship network connecting the top 25 collaborators of Marina Boni. A scholar is included among the top collaborators of Marina Boni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina Boni. Marina Boni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation 2019 ·Stem Cell Research ·Manuela Mura, (unknown), (unknown), Monia Ginevrino, Marina Boni, (unknown), Lia Crotti, Enza Maria Valente, Peter J. Schwartz, Hung‐Fat Tse, Massimiliano Gnecchi	1
2	Generation of two human induced pluripotent stem cell (hiPSC) lines from a long QT syndrome South African founder population 2019 ·Stem Cell Research ·Manuela Mura, (unknown), (unknown), Monia Ginevrino, Marina Boni, (unknown), Lia Crotti, Enza Maria Valente, Peter J. Schwartz, Paul A. Brink, Massimiliano Gnecchi	3
3	Generation of the human induced pluripotent stem cell (hiPSC) line PSMi006-A from a patient affected by an autosomal recessive form of long QT syndrome type 1 2019 ·Stem Cell Research ·Manuela Mura, (unknown), (unknown), Monia Ginevrino, (unknown), Marina Boni, Lia Crotti, Enza Maria Valente, Peter J. Schwartz, Massimiliano Gnecchi	4
4	Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation 2019 ·Stem Cell Research ·Manuela Mura, (unknown), (unknown), Monia Ginevrino, Marina Boni, (unknown), Lia Crotti, Enza Maria Valente, Peter J. Schwartz, Hung‐Fat Tse, Massimiliano Gnecchi	2
5	Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene 2019 ·Stem Cell Research ·Manuela Mura, (unknown), (unknown), Monia Ginevrino, Marina Boni, (unknown), Lia Crotti, Enza Maria Valente, Peter J. Schwartz, Paul A. Brink, Massimiliano Gnecchi	2
6	Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene 2018 ·Stem Cell Research ·Manuela Mura, (unknown), Monia Ginevrino, Rita Zappatore, (unknown), Marina Boni, Federica Dagradi, Lia Crotti, Enza Maria Valente, Peter J. Schwartz, Hung‐Fat Tse, Massimiliano Gnecchi	2
7	Mindfulness and avoidance mediate the relationship between yoga practice and anxiety 2018 ·Complementary Therapies in Medicine ·Marina Boni, Robert Schütze, Robert Kane, (unknown), Jean Byrne, Sarah J. Egan	12
8	MDS/AML del(11)(q14) Share Common Morphological Features Despite Different Chromosomal Breakpoints 2017 ·Anticancer Research ·(unknown), Rosangela Invernizzi, Marina Boni, Rita Zappatore, Ilaria Giardini, (unknown), Barbara Rocca, (unknown), (unknown), Marilena Caresana, Francesca Pasi, Rosanna Nano, Paolo Bernasconi	1
9	FuseFISH: Robust Detection of Transcribed Gene Fusions in Single Cells 2014 ·Cell Reports ·Stefan Semrau, Nicola Crosetto, Magda Bienko, Marina Boni, Paolo Bernasconi, Roberto Chiarle, Alexander van Oudenaarden	34
10	Detection of TET2 abnormalities by fluorescence in situ hybridization in 41 patients with myelodysplastic syndrome 2012 ·Cancer Genetics ·(unknown), Marina Boni, Marianna Rossi, Patrizia Zappasodi, (unknown), Rita Zappatore, Paola Maria Cavigliano, Ilaria Giardini, Barbara Rocca, Marilena Caresana, Cesare Astori, Mario Cazzola, Carlo Castagnola, Paolo Bernasconi	4
11	Does cytogenetic evolution have any prognostic relevance in myelodysplastic syndromes? A study on 153 patients from a single institution 2010 ·Annals of Hematology ·Paolo Bernasconi, Catherine Klersy, Marina Boni, Paola Maria Cavigliano, Ilaria Giardini, Barbara Rocca, Rita Zappatore, (unknown), (unknown), Marilena Caresana, Mario Lazzarino	16
12	Has Cytogenetic Evolution Any Prognostic Relevance in Myelodysplastic Syndromes (MDS)? A Study on 153 Patients. 2007 ·Blood ·(unknown), Catherine Klersy, Marina Boni, Paola Maria Cavigliano, Silvia Calatroni, Ilaria Giardini, Barbara Rocca, Rita Zappatore, (unknown), Marilena Caresana, (unknown)	1
13	ABL1 amplification in T-cell acute lymphoblastic leukemia 2005 ·Cancer Genetics and Cytogenetics ·Paolo Bernasconi, Silvia Calatroni, Ilaria Giardini, (unknown), Carlo Castagnola, Paola Maria Cavigliano, Barbara Rocca, Marina Boni, Jessica Quarna, Rita Zappatore, Marilena Caresana, (unknown), (unknown), Mario Lazzarino	17
14	Incidence and prognostic significance of karyotype abnormalities in de novo primary myelodysplastic syndromes: a study on 331 patients from a single institution 2005 ·Leukemia ·Paolo Bernasconi, Catherine Klersy, Marina Boni, Paola Maria Cavigliano, Silvia Calatroni, Ilaria Giardini, Barbara Rocca, Rita Zappatore, Marilena Caresana, Jessica Quarna, Mario Lazzarino, Carlo Bernasconi	59
15	Molecularly Targeted Therapy in Acute Myeloid Leukemia 2004 ·Annals of the New York Academy of Sciences ·Paolo Bernasconi, Marina Boni, Paola Maria Cavigliano, Silvia Calatroni, Ilaria Giardini, Barbara Rocca, Rita Zappatore, Marilena Caresana, Jessica Quarna	8
16	Is FISH a relevant prognostic tool in myelodysplastic syndromes with a normal chromosome pattern on conventional cytogenetics? A study on 57 patients 2003 ·Leukemia ·Paolo Bernasconi, Paola Maria Cavigliano, Marina Boni, Silvia Calatroni, Catherine Klersy, Ilaria Giardini, Barbara Rocca, Nicola Crosetto, Marilena Caresana, Mario Lazzarino, C Bernasconi	47
17	Molecular Genetics of Acute Myeloid Leukemia 2002 ·Annals of the New York Academy of Sciences ·Paolo Bernasconi, Marina Boni, Paola Maria Cavigliano, Silvia Calatroni, Ilaria Giardini, Barbara Rocca, Marilena Caresana	9
18	Long‐term follow up with conventional cytogenetics and band 13q14 interphase/metaphase in situ hybridization monitoring in monoclonal gammopathies of undetermined significance 2002 ·British Journal of Haematology ·Paolo Bernasconi, Paola Maria Cavigliano, Marina Boni, Cesare Astori, Silvia Calatroni, Ilaria Giardini, Barbara Rocca, Marilena Caresana, Nicola Crosetto, Mario Lazzarino, Carlo Bernasconi	12
19	Trisomy 11 and a Complex t(11;11;22) in a Patient with Acute Myelomonocytic Leukemia (AML-M4) Following Myelodysplasia (MDS) 2000 ·Cancer Genetics and Cytogenetics ·Paolo Bernasconi, Paola Maria Cavigliano, Marina Boni, Luca Malcovati, C. Astori, Carlo Castagnola, G. Pagnucco, Laura Vanelli, Silvia Calatroni, Marilena Caresana, Mario Lazzarino, Carlo Bernasconi	4
20	A Complex Translocation (5;7) in a Patient with Acute Nonlymphocytic Leukemia Evolved from a Myelodysplastic Syndrome 1998 ·Cancer Genetics and Cytogenetics ·Paolo Bernasconi, Paola Maria Cavigliano, Emilia Genini, Carlo Castagnola, Luca Malcovati, Silvia Calatroni, Marilena Caresana, Marina Boni, E. P. Alessandrino, C. Astori, Alessandro Corso, Carlo Bernasconi	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact